• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA's Banner Year For Approvals: Will Market Access To New Drugs Follow Suit?

cafead

Administrator
Staff member
  • cafead   Jan 21, 2019 at 11:02: AM
via It's not hyperbolic to say that 2018 was a sensational year for Food and Drug Administration (FDA) approvals of new drugs and biologics. And this occurred on the heels of a highly successful 2017, with the largest number of approvals in more than two decades.

article source
 

<